ResearcherUniversity of LouisvilleNo recent work listed

Shawn Peterson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7089-6012; OpenAlex author ID A5034882820. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper

Papers 1

Neoadjuvant Nab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible f… Co-author DOI 10.21873/anticanres.12692 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Gaurav Goel · 1 shared paper, 2018 · strength 0.07
- Paper Neoadjuvant Nab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenoca… DOI 10.21873/anticanres.12692 ↗
Peter J. Hosein · 1 shared paper, 2018 · strength 0.07
- Paper Neoadjuvant Nab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenoca… DOI 10.21873/anticanres.12692 ↗
Ching-Wei David Tzeng · 1 shared paper, 2018 · strength 0.07
- Paper Neoadjuvant Nab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenoca… DOI 10.21873/anticanres.12692 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.